Obesity Medicine Resources
Helpful Resources to Support Your Practice
Evidence-based obesity medicine research
Obesity Pillars® Journal
Our medical journal is dedicated to publishing evidence-based research for health care clinicians in the field of obesity medicine. Obesity Pillars® serves as a resource to assist clinicians to deliver patient-centered obesity medicine care in alignment with the OMA’s four pillars of obesity treatment: Nutrition Therapy, Physical Activity, Behavioral Modification, and Medical Interventions.
The Obesity Algorithm® is a comprehensive clinical tool designed to guide healthcare professionals in the assessment and management of obesity. This algorithm provides a structured framework for evaluating patients with obesity, offering a step-by-step approach to diagnosis, treatment, and ongoing care. The Obesity Algorithm is regularly updated to reflect the latest research and clinical guidelines.
Pediatric Obesity Algorithm
The Pediatric Obesity Algorithm® offers healthcare providers a structured approach for managing overweight and obesity in children and adolescents. This evidence-based tool draws from scientific research, medical knowledge, and the practical insights of pediatric clinicians who regularly address weight-related issues in young patients.
Customize your obesity medicine education and access the entire on-demand library of CME, ABOM Exam study materials, handouts, and other practical resources in the Obesity Medicine Academy.
OMA's pediatric resources encompass a wealth of educational materials, clinical guidelines, and research-based insights to aid healthcare professionals in effectively managing and preventing obesity in children and adolescents. OMA's commitment to combating pediatric obesity is reflected in its extensive pediatric-focused resources, empowering healthcare professionals to make a meaningful impact on the health and well-being of young patients.
Learn about the side effects of weight loss drugs, from digestive issues to long-term impacts. Get the facts before starting your regimen.
Today, there's renewed optimism due to the emergence of GLP1-based drug therapies like Wegovy (semaglutide) and Zepbound (tirzepatide), which demonstrate remarkable effectiveness for weight and health. Unfortunately, many of the available alternatives, like compounded versions of semaglutide and tirzepatide, are not what they are advertised to be. These companies stated that they do not sell the active ingredient to compounding pharmacies, and substances made or distributed by compounding pharmacies or other healthcare practitioners that claim to be semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) have not been reviewed by the FDA for safety, quality, or efficacy. For more information, see the following details: Compounded peptides: An Obesity Medicine Association Position Statement - ScienceDirect | Obesity Medicine Association Medications Containing Semaglutide Marketed for Type 2 Diabetes or Weight Loss | FDA Compounding and the FDA: Questions and Answers | FDA Open Letter Regarding the Use of Mounjaro® (tirzepatide) and Zepbound™ (tirzepatide) | Eli Lilly and Company Responsible Use Letter | Novo Nordisk Things You Should Know About Compounded Anti-Obesity (AOM) Medications | Obesity Medicine Association
Official podcast of the OMA
Obesity: A Disease
Podcast episodes provide valuable insights into treating the disease of obesity and better equip clinicians to understand and engage in treating this disease.
Obesity Medicine Job Board
A comprehensive and dynamic platform for individuals seeking employment opportunities in various fields. It is a valuable resource for job seekers by providing diverse job listings from reputable organizations spanning industries such as technology, healthcare, psychology, and more. Users can browse through a variety of job postings, including full-time, part-time, remote, and internships, catering to a broad spectrum of career needs. The OMA job board also offers a job submission feature where users can submit their own job listings.